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Opportunistic fungal infections account for a
significant amount of morbidity associated with
HIV disease. In Northern Ireland approximately
10% of our HIV positive patients have acquired
their disease in foreign climes, particularly sub-
SaharanAfricaandtheUnitedStatesofAmerica.
This, coupled with increasing travel in general
abroad, increasesthelikelihoodofthemacquiring
opportunistic infections notoften encountered in
the United Kingdom. We report here a case of
localised oral histoplasmosis without evidence
ofdisseminated disease in a patient who hadjust
been diagnosed as having HIV infection.
Reactivation of latent histoplasma infection
occurred as aresultofpreviousexposureinSouth
Africafollowinggradualdepletionofhis immune
function by HIV infection.
CASE REPORT
History
A 51 yearoldheterosexual malepresented to our
department in May 2000. He hadbeendiagnosed
with palatal histoplasmosis one weekpreviously
in South Africa prompting a HIV test which
returned as positive. He had immediately flown
backhome toNorthern Ireland fortreatment. His
symptoms started in 1996 when he developed
recurrent mouth ulcers and overgrowth of his
gums. This persisted and in 1999 he developed a
cough,intermittentlyproductiveofgreensputum,
recurrent fevers, and boils in the axillae and
groins. In January 2000 his symptoms had
increased in severity to such an extent that they
wereaffecting his ability to eatanddrink. He was
unable to expectorate sputum because ofpain in
his mouth. He attended both his general
practitioneranddentistoverthefollowingmonths
wherehewasdiagnosedashavingrecurrentchest
infections and blocked sinuses respectively. He
failed to respond to antibiotic treatment. Upon
Fig 1. Necrotic ulcerated lesion on the hard palate.
referral to an oral surgeon in April a palatal
biopsy revealed histoplasmosis infection. A
subsequent HIV test was positive.
Since leaving the United Kingdom in the 1960s
he had lived and worked in different African
countries, finally settlingin SouthAfrica. Hehad
had multiple heterosexual encounters which
included professional sex workers.
Examinationrevealedawelllooking manwith an
ulcerated necrotic area on the roof of his mouth
(figure 1). A raised nodule 0.5 cm in diameter
was present on the dorsum ofthe right hand. The
rest of the examination was unremarkable.
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Fig 2. X-ray of maxillae showing right sided mucosal
antral thickening.
Investigations revealedanormal whitecell count
but areduced lymphoctye count-0.9 x 10/L (1.5
- 3.5). His CD4 count was 0.06 x 109 /L (0.5 -
1.6). Confirmatory HIV testing was positive.
Microscopy of sputum showed occasional pus
andepithelialcells. Cultureofsputum, bloodand
a swab of the palatal ulcer showed no growth.
Analysis of urine for histoplasma antigen was
negative. A chest radiograph was normal but a
radiographoffacialbonesshowedmaxillaryantral
mucosal thickening ofthe lateral wall (figure 2).
HistologyofapalatalbiopsyobtainedfromSouth
Africa showed an inflammatory infiltration of
mainly histiocytes in the subepithelial stroma
with areas of necrosis. PAS staining revealed
smallfungalorganismslyingwithinthecytoplasm
ofthe histiocytes (figure 3). Biopsy ofthe lesion
on the hand showed it to be molluscum
contagiosum.
Treatment with intravenous amphotericin B
encapsulated in lysosomes at a dose of0.5mg/kg
was given for two weeks. Thereafter oral
antifungal treatment in the form of itraconazole
200mg daily was the commenced. Prophylaxis
for pneumocystis carini infection with
cotrimoxazole was changed to dapsone 100 mg
daily following development of a widespread
maculopapularrash. His cough settled within the
Fig 3. Palatal biopsy with PAS staining showing a
granuloma with a necrotic centre in which small
fungal organisms of histoplasma may be seen
( x40).
first week and the palatal lesions had gradually
regressed. Repeat blood investigations showed
his CD4 count to have increased to 0.11 x lO/L.
Afterdiscussionwiththepatient anantiretroviral
regime was chosen and commenced.
DISCUSSION
This 51 year old man had symptoms suggestive
of oral histoplasmosis for four years prior to a
definitive diagnosis. This led to the diagnosis of
co-existent HIV infection. He responded very
welltoantifungal treatment. Attemptstodiagnose
infection at other sites (for example, paranasal
sinuses) were not undertaken as his response to
treatment was so prompt.
Histoplasma capsulatum is a dimorphic fungus,
distributedworldwidebetween latitudes 45 north
and 30 south of the equator. It is endemic in
certain areas of north and south America, where
it remains a major healthproblem.1 It is acquired
by inhalation of fragments of the mycelial form
which are deposited inthe pulmonary alveoli and
converted to the yeast form at body temperature.
CD4 T lymphocytes are crucial to the host's
defence, hence the susceptibility of
immunocompromised individuals.2
In immunocompetent individuals 90% of
infections are asymptomatic. In HIV positive
patients histoplasmosis usually presents as a
disseminated infection and is categorised as an
AIDS defining illness in such patients. It has
beenreported asthe second orthird mostfrequent
opportunistic infection in HIV positive patients
living in endemic areas.2
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The pattern of clinical presentation is varied -
fever, weight loss, respiratory complaints,
lymphadenopathy,hepatosplenomegaly, skinand
oral lesions I and central nervous system
involvement can occur with 5 - 10% of patients
presenting with symptoms of septic shock.4
Blood tests may show anaemia, neutropenia or
thrombocytopenia reflecting bone marrow
involvementwiththefungus. Liverfunctiontests
may be abnormal.
Diagnosis is based on culture ofthe fungus from
blood, sputum or other clinical specimens.
Histopathologicalexaminationofbiopsymaterial
(eg. lung, skin), bone marrow aspirate or lavage
fluid may also be diagnostic.
Detectionofanti-histoplasmaantibodiesinserum
by either immunodiffusion techniques or a
complement fixation test yields a sensitivity of
70-80%. However 30-50% of immuno-
compromised individuals fail to develop
detectable titres of antibody.
Detection ofhistoplasma antigen in the urine or
serum yields sensitivities of 90 and 50%
respectively. Itisusefulinimmunocompromised
patients and allows serial monitoring to assess
response to therapy, however it is not widely
available.S
Treatment withamphotericin B atadoseof0.5 to
1.0 mg/kg for a total dose of0.5 to 1.0 gm gives
a response rate of 85-90%. Amphotericin B
encapsulated in liposomes is being increasingly
used as it causes fewer adverse reactions.
Itraconazole orally at a dose of 400 mg daily
showed aresponse rateof85%, howeverpatients
with severe life threatening illness or central
nervous systeminvolvementwereexcludedfrom
this study.2
Suppressive therapy with itraconazole a dose of
200 to 400 mg daily has been shown to behighly
effective in preventing relapse whether initial
treatment was with amphotericin B or
itraconazole. AmphotericinBgivenbyweekly or
biweekly infusion resulted in 85-90% relapse
free survival but may require an indwelling
intravenous catheter. Long term continuation of
maintenance treatment is recommended.3
Future therapies may include chloroquine which
has been shown to greatly augment the ability of
human macrophages to inhibit the intracellular
growth of histoplasma yeasts. Nikkomycin Z is
highly active against Histoplasma capsulatum in
vitro. It has been shown to treat murine
histoplasmosis successfully but has not yet been
trialed in humans. A vaccine, made from the
glycoproteinyeastwall,hasbeenshowntoconfer
protectiveimmunityinmiceagainstexperimental
infection. A human vaccine may be ofbenefit in
the immunocompromised patient or military
personnel in endemic areas, or those exposed to
histoplasma occupationally.
TheincidenceofHIVinfectioninNorthernIreland
continues to rise with a significant number of
patients originating from Africa and America.
Travel to distant climes, is increasing. It is very
likely that in the future more cases of fungal
infection, previously viewed as exotic, will be
seen by doctors and dentists here.
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